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WE investigated  the  effect  of  ferulic  acid  (FA)  and
isoferulic  acid  (IFA),  which  are  the  main  active
components of the rhizoma of Cimicifuga heracleifo-
lia (CH), an anti-inflammatory drug used frequently
in Japanese traditional medicine, on the production
of macrophage inflammatory protein-2 (MIR-2)  in a
murine macrophage cell line, RAW264.7, in response
to respiratory syncytial virus (RSV) infection. Follow-
ing the exposure of cells to RSV for 20h, the MIP-2
level  in  condition  medium  was  increased  to  about
20ng/ml, although this  level  in mock-infected cells
was negligible. In the presence of either FA or IFA,
RSV-infected  cells  reduced  MIP-2  production  in  a
dose-dependent manner.  These data suggest  that FA
and IFA might be responsible, at least in part, for the
anti-inflammatory drug effect of CH extract through
the inhibition of MIP-2 production.
Key  words:  Respiratory  syncitial  virus,  Murine  macro-
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Introduction
Respiratory syncytial virus (RSV) is the major cause of
acute lower respiratory tract illnesses such as bron-
chiolitis  and  pneumonia  in  infants  and  young  chil-
dren, and can cause severe, even fatal, infections in
the elderly.1 Several studies have indicated that RSV is
released  initially  from upper  respiratory tract infec-
tions  and then  reaches  the  bronchoalveolar  region,
where  viruses  induce  inflammation  of  the  airway
epithelium accompanied by peribronchiolar infiltra-
tions  of  neutrophils.1,2 It  is  well  known  that  neu-
trophil accumulation is an important characteristic of
inflammation  and  modulates  various  inflammatory
reactions.3 Since the initial discovery of interleukin-8
as a novel neutrophil chemotactic cytokine,4–6 it has
since been named a chemokine and been found in the
conditioned  medium  (CM)  of  various  cells  in
response to stimulation with lipopolysaccharide (LPS)
as  well  as  several  virus  infections.  We  previously
reported  that  RSV  infection  strongly  induces  the
production  of  macrophage  inflammatory  protein-2
(MIP-2), a murine counterpart of chemokine family,7
in RAW 264.7 cells.8,9
On the other hand, the rhizoma of Cimicifuga sp.,
such as Cimicifuga heracleifolia (CH) Komarov and
Cimicifuga dahurica Maxim are used frequently as
antipyretic, analgesic and anti-inflammatory drugs in
Japanese  traditional  medicine.  Ferulic  acid  (FA),
3-(4-hydroxy-3-methoxyphenyl)-2-propenic  acid  and
its  isomer  isoferulic  acid  (IFA),  3-(3-hydroxy-
4-methoxyphenyl)-2-propenic,  have  been  recently
recognized  as  the  main  active  components  of  CH
extract in the inflammation model in rats.10
In the light of these findings, we examined whether
FA and IFA show inhibitory effects on MIP-2 produc-
tion in response to RSV infection.
Materials  and  methods
Preparation  of  drugs
FA and IFA, purchased from Carl Roth GmbH (Karls-
ruhe, Germany), were freshly prepared in serum-free
Dulbecco’s  modified  Eagle’s  minimal  essential
medium  (DMEM)  at  a  concentration  of  5 mM. The
dissolved  drugs  were  strilized  through  a  Millipore
filter before use.
Cell
A  murine  macrophage  cell  line,  RAW264.7,  was
obtained from American Type Culture Collection and
maintained in culture with DMEM supplemented with
10%  fetal  bovine  serum  (FBS),  in  a  humidified
atmosphere containing 5% CO2 at 37°C. Hep-2 cells
were cultured in MEM supplemented with 10% of FBS
in the same manner as above.
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RSV  A2  strain,  which  was  kindly  supplied  by  Dr
Watanabe  (Rational  Drug  Design  Laboratories,
Fukushima,  Japan),  was  propagated  in  a  confluent
monolayer of Hep-2 cells in a maintenance medium
(MEM  supplemented  with  2%  FBS).1 When  the
cytopathic  effect  reached  80%,  the  cultures  were
processed with three cycles of freezing and thawing.
After centrifugation at 20003 g for 10 min, the culture
supernatant  was  collected  and  stored  in  a  small
portion at –84°C as a virus stock solution. Virus titers
were  determined  as  plaque-forming  units  (PFU)  on
Hep-2 cells as described previously.1
RSV  infection
RAW  264.7  cells  were  inoculated  into  a  96-well
microplate  at  a  density  of  13 105 cells/well  and
cultured overnight at 37°C. Thereafter, the cells were
washed once with serum-free media and exposed for
3 h at 37°C to 20 m l of virus solution at a multiplicity
of infection (MOI) of 3 PFU/cell. After virus adsorp-
tion, 200 m l  of serum-free medium with or without
drugs  were  added  (0h  post-infection)  and  further
cultured for additional time periods as indicated.
MIP-2  assay
MIP-2 levels in the CM were examined by antibody-
sandwich  enzyme-linked  immunosorbent  assay
(ELISA)  in  which  rabbit  unlabeled  and  biotinylated
anti-murine MlP-2 antibodies were used as the capture
and  second-layer  antibodies,  respectively,  as  descri-
bed previously.11 Purified MIP-2 was used for standar-
dization of MIP-2 levels, and MIP-2 levels in  experi-
mental groups were expressed as percent of control
culture, in which infected cells were cultured in the
absence of drugs. For statistical analysis, three wells
were used for each experimental point.
Statistical  analysis
The results were expressed as mean±standard devia-
tion (SD). The differences were examined by Bonfer-
roni’s least-significant difference test.
Results  and  discussion
In  the  control  culture,  MIP-2  levels  in  the  CM
increased  to  the  level  of  20.4±0.8 ng/ml  until  20 h
after  infection  in  a  time-dependent  manner.  In  the
uninfected cells, no significant production (less than
0.5 ng/ml)  was  observed  throughout  the  experi-
ments  (data  not  shown).  When  the  infected  cells
were cultured in the presence of FA and IFA, these
drugs  showed  inhibitory  effects  on  MIP-2  produc-
tion  in  a  dose-dependent  manner.  At  20 h,  FA
reduced MIP-2 levels to 74.4 and 42.8% of control at
doses  of  50  and  500m M,  respectively  (Fig.  1).  In
addition, IFA also reduced MIP-2 levels to 61.8, 58.0
and 35.6% of control at doses of 5, 50 and 500 m M,
respectively (Fig. 2). These values were significantly
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FIG. 1. Inhibitory effect of FA on MIP-2 production in
RAW264.7  cells  in  response  to  RSV  infection.  RAW264.7  cells
were infected with RSV at an MOI of 3PFU/cell. After
absorption  for  1h,  the  cells  were  cultured  in  the  presence  of
FA at the indicated concentrations (open bar). The MIP-2
levels in 20-h conditioned media were determined and
expressed  as  MIP-2  level  by  percent  of  control  cultured  in  the
absence  of  drugs  (closed  bar).  Asterisks  indicate  a  significant
difference from control with a P value of <0.05. Data are
shown as the mean (thick bar)± SD (thin bar) of three
determinations.
FIG. 2. Inhibitory effect of IFA on MIP-2 production in
RAW264.7  cells  in  response  to  RSV  infection.  RAW264.7  cells
were  infected  with  RSV  by  the  same  manner  as  described  in
the  legend  for  Fig.  1.  After  absorption  for  1h,  the  cells  were
cultured in the  presence of IFA  at the  indicated  concentra-
tions  (open  bar).  The  MIP-2  levels  in  20-h  conditioned  media
were  determined  and  expressed  as  MIP-2  level  by  percent  of
control cultured in the absence of drugs (closed bar).
Asterisks  indicate  a  significant  difference  from  control  with  a
P value  of  <0.05.  Data  are  shown  as  the  mean  (thick  bar)± SD
(thin  bar)  of  three  determinations.lower  than that  of the control. At  the highest dose
(500 m M), both FA  and IFA  reduced MIP-2 levels to
42.8  and  35.6%  of  the  control,  respectively.  In
contrast to FA, IFA exhibited a significant inhibitory
effect even at the lowest dose (5m M). The cytotoxic
effect  of  FA  or  IFA  treatment  at  500m M  for  24 h
could  be  ruled  out  by Trypan  blue  exclusion  test,
that  is, FA- or IFA-treated cells were viable at  more
than  95% which  was comparable to  drug-untreated
cells.
In Japanese oriental medicines, the rhizoma of CH
are used frequently as antipyretic, analgesic and anti-
inflammatory  drugs,  and  FA  and  IFA  have  been
recently recognized as the main  active components
of  CH  extract  in  the  inflammation  model  in  rats.10
However,  the  mechanisms  of  anti-inflammatory
effect of FA and IFA are not understood completely.
In  addition  to  a  previous  report  indicating  that  FA
inhibits MIP-2 production in response to LPS stimula-
tion in  RAW264.7  cells,12 this study confirmed that
both  FA  and  IFA  inhibit  MIP-2  production  even  in
response  to  RSV  infection  in  RAW264.7  cells  in  a
dose-dependent  manner. Since  peribronchiolar  infil-
trations of neutrophils are important pathogenesis in
RSV  infections,13,14 MIP-2-inducing  activity  of  RSV
should play a key role. Taking into account the fact
that  neutrophils  can  cause  tissue  injuries,  such  as
lung damage  in  adult  respiratory  distress  syndrome
and  other  inflammatory  diseases,  through  the  pro-
duction of superoxide or some enzymes, in addition
to  killing  ingested  or  invading  microbes,15 –17 these
data  suggest  that  FA  and  IFA  might  contribute  at
least in part  to the anti-inflammatory drug effect of
CH  extract  through  the  reduction  of  MIP-2  levels,
and  thereby  the reduction  of neutrophil infiltration
into  the inflammatory  sites. In  addition, the use of
FA  and IFA  or CH extract seems to be a novel and
attractive strategy for control of pneumonia induced
by  certain  virus  infections,  including  RSV
infection.
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